First Tracks Biotherapeutics Inc

TRAX | NASDAQ

$44.30

-$0.78 (-1.73%)

Nov 2, 2026, 12:06 PM ET · Market open

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q1 2025 Mar 31, 2025
PE Ratio	-8.42	-13.10	n/a	-13.97
PEG Ratio	0.24	n/a	n/a	n/a
PS Ratio	n/a	n/a	n/a	n/a
PB Ratio	4.22	2.56	n/a	1.69
P/FCF Ratio	-11.04	-20.27	n/a	-14.66
P/OCF Ratio	-11.04	-20.28	n/a	-14.67
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0.03	n/a	0.05	n/a
Quick Ratio	14.28	8.74	10.20	n/a
Current Ratio	14.28	8.74	10.20	n/a
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	n/a
Return on Equity	-19.77%	-19.61%	n/a	-12.05%
Return on Assets	-18.22%	-17.37%	n/a	n/a
Return on Invested Capital	-20.18%	-20.51%	n/a	n/a
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a